{
    "Trade/Device Name(s)": [
        "RPMI 1640 Agar w/ MOPS and 2% Glucose"
    ],
    "Submitter Information": "Remel Inc. (Thermo Fisher Scientific)",
    "510(k) Number": "K072827",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MJE"
    ],
    "Summary Letter Date": "October 1, 2007",
    "Summary Letter Received Date": "October 3, 2007",
    "Submission Date": "July 14, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.1700"
    ],
    "Regulation Name(s)": [
        "Culture medium for antimicrobial susceptibility test"
    ],
    "Analyte Class(es)": [
        "mycology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Candida species"
    ],
    "Specimen Type(s)": [
        "Microbial colony"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Antibiotic gradient-based system"
    ],
    "Methodologies": [
        "Gradient method for antifungal susceptibility testing"
    ],
    "Submission Type(s)": [
        "Medium",
        "Plated medium"
    ],
    "Document Summary": "FDA 510(k) summary for Remel RPMI 1640 Agar w/ MOPS and 2% Glucose used in gradient-based antifungal susceptibility testing of Candida spp.",
    "Indications for Use Summary": "Recommended for use with antibiotic gradient-based systems for quantitative determination of susceptibility to antifungal agents when testing Candida spp. directly from colonies grown on nonselective media.",
    "fda_folder": "Microbiology"
}